Cameron Kevin J 4
4 · KERYX BIOPHARMACEUTICALS INC · Filed May 31, 2018
Insider Transaction Report
Form 4
Cameron Kevin J
Director
Transactions
- Sale
Common Stock
2018-05-29$5.22/sh−1,667$8,702→ 168,333 total
Footnotes (2)
- [F1]Sale of a total of 1,667 shares of common stock was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 8, 2017.
- [F2]Includes 16,666 shares of restricted stock.